Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Validation of Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event-Free Survival in Intermediate and High-Risk Hodgkin Lymphoma

Lianna J. Marks, Yiwang Zhou, Ying Zheng, Angela Feraco, Alison M. Friedmann, Howard J. Weinstein, Michael P. Link, Jamie E. Flerlage

Blood (2023) 142 (Supplement 1): 4451.

https://doi.org/10.1182/blood-2023-189991

Published: 2023

Journal Articles

Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement

Abner Louissaint, Jr, Adam M. Ackerman, Dora Dias-Santagata, Judith A. Ferry, Ephraim P. Hochberg, Mary S. Huang, A. John Iafrate, Daniel O. Lara, Geraldine S. Pinkus, Itziar Salaverria, Zakir Siddiquee, Reiner Siebert, Howard J. Weinstein, Lawrence R. Zukerberg, Nancy Lee Harris, Robert P. Hasserjian

Blood (2012) 120 (12): 2395–2404.

https://doi.org/10.1182/blood-2012-05-429514

Published: 2012

Includes: Supplemental data

Journal Articles

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML

Blood (2010) 115 (12): 2372–2379.

https://doi.org/10.1182/blood-2009-09-241075

Published: 2010

Journal Articles

Acute Megakaryoblastic Leukemia (AMKL) in Children without Down Syndrome.

Maureen O'Brien, MD, Gary Dahl, MD, Stanley Pounds, Norman J. Lacayo, MD, Jeffrey Taub, MD, Myron Chang, Howard J. Weinstein, MD, Yaddanapudi Ravindranath, MBBS, Dario Campana, MD, PhD, Ching-Hon Pui, MD, Jeffrey Rubnitz, MD, PhD

Blood (2009) 114 (22): 482.

https://doi.org/10.1182/blood.V114.22.482.482

Published: 2009

Journal Articles

High-Dose Methotrexate and Early Intensification of Therapy Do Not Improve 3 Year EFS in Children and Adolescents with Disseminated Lymphoblastic Lymphoma. Results of the Randomized Arms of COG A5971

Minnie Abromowitch, MD, Amanda Termuhlen, MD, Myron Chang, PhD, Sherrie L. Perkins, MD, PhD, Thomas Gross, MD, PhD, Howard J. Weinstein, MD, Jonathan Finlay, MD

Blood (2008) 112 (11): 3610.

https://doi.org/10.1182/blood.V112.11.3610.3610

Published: 2008

Journal Articles

Gene Expression Profiling Predicts Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Norman J. Lacayo, MD, Maureen O’Brien, MD, Shweta Jain, Soheil Meshinchi, MD, PhD, Ron Yu, PhD, Dejan Juric, MD, Myron N. Chang, PhD, Robert Tibshirani, PhD, Yaddanapudi Ravindranath, MD, Howard J. Weinstein, MD, Branimir I. Sikic, MD, Gary Van Houten Dahl, MD

Blood (2006) 108 (11): 1915.

https://doi.org/10.1182/blood.V108.11.1915.1915

Published: 2006

Journal Articles

A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481

Gita V. Massey, Alvin Zipursky, Myron N. Chang, John J. Doyle, Suhail Nasim, Jeffrey W. Taub, Yaddanapudi Ravindranath, Gary Dahl, Howard J. Weinstein

Blood (2006) 107 (12): 4606–4613.

https://doi.org/10.1182/blood-2005-06-2448

Published: 2006

Journal Articles

Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia

Yubin Ge, Alan A. Dombkowski, Katherine M. LaFiura, Dana Tatman, Ravikiran S. Yedidi, Mark L. Stout, Steven A. Buck, Gita Massey, David L. Becton, Howard J. Weinstein, Yaddanapudi Ravindranath, Larry H. Matherly, Jeffrey W. Taub

Blood (2006) 107 (4): 1570–1581.

https://doi.org/10.1182/blood-2005-06-2219

Published: 2006

Journal Articles

Array CGH Discovers Novel Genomic Signatures in De Novo Acute Myeloid Leukemia (AML): Results of Children’s Oncology Group (COG) Study POG #9421.

Dennis J. Kuo, MD, Norman J. Lacayo, MD, Don Hoang, Dejan Juric, MD, Susana C. Raimondi, PhD, David Chen, Myron N. Chang, PhD, Yaddanapudi Ravindranath, MD, Howard J. Weinstein, MD, Branimir I. Sikic, MD, Gary Van Houten Dahl, MD

Blood (2005) 106 (11): 2771.

https://doi.org/10.1182/blood.V106.11.2771.2771

Published: 2005

Journal Articles

Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience.

Jacob M. Rowe, MD, Xiaochun Li, Peter A. Cassileth, MD, Frederick R. Appelbaum, MD, Charles A. Schiffer, MD, Peter H. Wiernik, MD, Mark R. Litzow, MD, Larry D. Cripe, MD, Hillard M. Lazarus, MD, Elisabeth Paietta, Ph.D, Gordon W. Dewald, MD, Howard J. Weinstein, MD, Angela K. Ogden, MD, William G. Woods, MD, Lois Shepherd, MD, James H. Feusner, MD, Clara D. Bloomfield, MD, Martin S. Tallman, MD

Blood (2005) 106 (11): 546.

https://doi.org/10.1182/blood.V106.11.546.546

Published: 2005

Journal Articles

Chromosomal Abnormalities in 478 Children With Acute Myeloid Leukemia: Clinical Characteristics and Treatment Outcome in a Cooperative Pediatric Oncology Group Study—POG 8821

Susana C. Raimondi, Myron N. Chang, Yaddanapudi Ravindranath, Frederick G. Behm, Mary V. Gresik, C. Philip Steuber, Howard J. Weinstein, Andrew J. Carroll

Blood (1999) 94 (11): 3707–3716.

https://doi.org/10.1182/blood.V94.11.3707

Published: 1999

Journal Articles

Expression of Chromosome 21-Localized Genes in Acute Myeloid Leukemia: Differences Between Down Syndrome and Non-Down Syndrome Blast Cells and Relationship to In Vitro Sensitivity to Cytosine Arabinoside and Daunorubicin

Jeffrey W. Taub, Xi Huang, Larry H. Matherly, Mark L. Stout, Steven A. Buck, Gita V. Massey, David L. Becton, Myron N. Chang, Howard J. Weinstein, Yaddanapudi Ravindranath

Blood (1999) 94 (4): 1393–1400.

https://doi.org/10.1182/blood.V94.4.1393

Published: 1999

Journal Articles

Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines

Kyriaki Dunussi-Joannopoulos, Glenn Dranoff, Howard J. Weinstein, James L.M. Ferrara, Barbara E. Bierer, James M. Croop

Blood (1998) 91 (1): 222–230.

https://doi.org/10.1182/blood.V91.1.222

Published: 1998

Journal Articles

CD8 + T Cells Activated During the Course of Murine Acute Myelogenous Leukemia Elicit Therapeutic Responses to Late B7 Vaccines After Cytoreductive Treatment

Kyriaki Dunussi-Joannopoulos, Werner Krenger, Howard J. Weinstein, James L.M. Ferrara, James M. Croop

Blood (1997) 89 (8): 2915–2924.

https://doi.org/10.1182/blood.V89.8.2915

Published: 1997

NARROW

Validation of Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event-Free Survival in Intermediate and High-Risk Hodgkin Lymphoma

Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML

Acute Megakaryoblastic Leukemia (AMKL) in Children without Down Syndrome.

High-Dose Methotrexate and Early Intensification of Therapy Do Not Improve 3 Year EFS in Children and Adolescents with Disseminated Lymphoblastic Lymphoma. Results of the Randomized Arms of COG A5971

Gene Expression Profiling Predicts Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481

Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia

Array CGH Discovers Novel Genomic Signatures in De Novo Acute Myeloid Leukemia (AML): Results of Children’s Oncology Group (COG) Study POG #9421.

Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience.

Chromosomal Abnormalities in 478 Children With Acute Myeloid Leukemia: Clinical Characteristics and Treatment Outcome in a Cooperative Pediatric Oncology Group Study—POG 8821

Expression of Chromosome 21-Localized Genes in Acute Myeloid Leukemia: Differences Between Down Syndrome and Non-Down Syndrome Blast Cells and Relationship to In Vitro Sensitivity to Cytosine Arabinoside and Daunorubicin

Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines

CD8 + T Cells Activated During the Course of Murine Acute Myelogenous Leukemia Elicit Therapeutic Responses to Late B7 Vaccines After Cytoreductive Treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only